Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.

Prion diseases or Transmissible Spongiform Encephalopathies (TSEs) are a group of fatal neurodegenerative disorders affecting several mammalian species. Its causative agent, disease-associated prion protein (PrPd), is a self-propagating β-sheet rich aberrant conformation of the cellular prion protein (PrPC) with neurotoxic and aggregation-prone properties, capable of inducing misfolding of PrPC molecules. PrPd is the major constituent of prions and, most importantly, is the first known example of a protein with infectious attributes. It has been suggested that similar molecular mechanisms could be shared by other proteins implicated in diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis or systemic amyloidoses. Accordingly, several terms have been proposed to collectively group all these disorders. Through the stringent evaluation of those aspects that characterise TSE-causing prions, in particular propagation and spread, strain variability or transmissibility, we will discuss whether terms such as "prion", "prion-like", "prionoid" or "propagon" can be used when referring to the aetiological agents of the above other disorders. Moreover, it will also be discussed whether the term "infectious", which defines a prion essential trait, is currently misused when referring to the other misfolded proteins.

[1]  Yvonne S. Eisele,et al.  The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain , 2011, Acta Neuropathologica.

[2]  D. Cui,et al.  Acceleration of murine AA amyloidosis by oral administration of amyloid fibrils extracted from different species , 2002, Pathology international.

[3]  N. Shneider,et al.  The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. , 2011, The Journal of clinical investigation.

[4]  B. Caughey,et al.  Prions and the potential transmissibility of protein misfolding diseases. , 2013, Annual review of microbiology.

[5]  Gordon Ws Advances in veterinary research. , 1946 .

[6]  N. Hunter,et al.  Prion diseases are efficiently transmitted by blood transfusion in sheep. , 2008, Blood.

[7]  Ewout J. N. Groen,et al.  Protein aggregation in amyotrophic lateral sclerosis , 2013, Acta Neuropathologica.

[8]  N. Cashman,et al.  TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion , 2016, Scientific Reports.

[9]  B. Caughey,et al.  Effect of Glycosylphosphatidylinositol Anchor-dependent and -independent Prion Protein Association with Model Raft Membranes on Conversion to the Protease-resistant Isoform* , 2003, The Journal of Biological Chemistry.

[10]  A. Kincaid,et al.  Rapid Prion Neuroinvasion following Tongue Infection , 2003, Journal of Virology.

[11]  Brian J. Wiltgen,et al.  Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-b , 2012 .

[12]  M. Staufenbiel,et al.  Soluble Aβ Seeds Are Potent Inducers of Cerebral β-Amyloid Deposition , 2011, The Journal of Neuroscience.

[13]  Jacob I. Ayers,et al.  Experimental transmissibility of mutant SOD1 motor neuron disease , 2014, Acta Neuropathologica.

[14]  Sebastian Brandner,et al.  Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy , 2015, Nature.

[15]  B. Ghetti,et al.  Gerstmann-Sträussler-Scheinker disease subtypes efficiently transmit in bank voles as genuine prion diseases , 2016, Scientific Reports.

[16]  D. Geschwind,et al.  Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism , 2015, Proceedings of the National Academy of Sciences.

[17]  Nicole F. Liachko,et al.  Phosphorylation Promotes Neurotoxicity in a Caenorhabditis elegans Model of TDP-43 Proteinopathy , 2010, The Journal of Neuroscience.

[18]  Masato Hasegawa,et al.  Prion-like spreading of pathological α-synuclein in brain , 2013, Brain : a journal of neurology.

[19]  M. Zabel,et al.  A brief history of prions. , 2015, Pathogens and disease.

[20]  P. Andersen,et al.  Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis. , 2013, Human molecular genetics.

[21]  A. Espenes,et al.  Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[22]  H. Wille,et al.  Conformational Diversity of Wild-type Tau Fibrils Specified by Templated Conformation Change* , 2009, Journal of Biological Chemistry.

[23]  P. Westermark,et al.  Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  F. Cohen,et al.  Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.

[25]  Björn Granseth,et al.  Spreading of Neurodegenerative Pathology via Neuron-to-Neuron Transmission of β-Amyloid , 2012, The Journal of Neuroscience.

[26]  P. Szekeres,et al.  Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates , 2014, The Journal of Biological Chemistry.

[27]  E. Bigio,et al.  Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Prusiner,et al.  Genetics of prion diseases and prion diversity in mice. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[29]  E. Mandelkow,et al.  ‘Prion-Like’ Propagation of Mouse and Human Tau Aggregates in an Inducible Mouse Model of Tauopathy , 2010, Neurodegenerative Diseases.

[30]  T. Matsui,et al.  Experimental induction of amyloidosis by bovine amyloid fibrils in Sore Hock rabbits , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[31]  B. Ghetti,et al.  Brain homogenates from human tauopathies induce tau inclusions in mouse brain , 2013, Proceedings of the National Academy of Sciences.

[32]  S. Prusiner,et al.  Some speculations about prions, amyloid, and Alzheimer's disease. , 1984, The New England journal of medicine.

[33]  J. Hardy,et al.  Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.

[34]  Xuebing Ding,et al.  Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure , 2015, Oncotarget.

[35]  T. Crow,et al.  Experimental Induction of β‐Amyloid Plaques and Cerebral Angiopathy in Primates a , 1993 .

[36]  Stephen J. DeArmond,et al.  Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions , 2012, Proceedings of the National Academy of Sciences.

[37]  B. Maddison,et al.  Prion transmission , 2010, Prion.

[38]  Yong-jian Liu,et al.  FUS Transgenic Rats Develop the Phenotypes of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration , 2011, PLoS genetics.

[39]  Christian Ducrot,et al.  Review on the epidemiology and dynamics of BSE epidemics. , 2008, Veterinary research.

[40]  T. Golde,et al.  Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein , 2013, Acta neuropathologica communications.

[41]  Richard I. Morimoto,et al.  Adapting Proteostasis for Disease Intervention , 2008, Science.

[42]  J. Trojanowski,et al.  Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer’s disease or corticobasal degeneration brains , 2015, Acta Neuropathologica.

[43]  Hans-Ulrich Demuth,et al.  Prion-Like Behavior and Tau-dependent Cytotoxicity of Pyroglutamylated β-Amyloid , 2012, Nature.

[44]  E. Hoover,et al.  Chronic wasting disease of cervids: current knowledge and future perspectives. , 2015, Annual review of animal biosciences.

[45]  S. Prusiner,et al.  A Unifying Role for Prions in Neurodegenerative Diseases , 2012, Science.

[46]  K. Shannon,et al.  Alpha‐synuclein in colonic submucosa in early untreated Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[47]  M. Staufenbiel,et al.  Multiple Factors Contribute to the Peripheral Induction of Cerebral β-Amyloidosis , 2014, The Journal of Neuroscience.

[48]  M. Staufenbiel,et al.  Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. , 2007, The American journal of pathology.

[49]  TIKVAH ALPER,et al.  Does the Agent of Scrapie Replicate without Nucleic Acid ? , 1967, Nature.

[50]  Inga Kadish,et al.  Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic mice , 2006, Neurobiology of Disease.

[51]  A. Roher,et al.  Exogenous induction of cerebral β-amyloidosis in βAPP-transgenic mice , 2002, Peptides.

[52]  S. Prusiner,et al.  Viroids and prions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[53]  S. Prusiner,et al.  Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients , 2014, Proceedings of the National Academy of Sciences.

[54]  Frank Baumann,et al.  Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis , 2010, Science.

[55]  S. Carver,et al.  Detection of Chronic Wasting Disease Prions in Salivary, Urinary, and Intestinal Tissues of Deer: Potential Mechanisms of Prion Shedding and Transmission , 2011, Journal of Virology.

[56]  B. Malissen,et al.  Determining the role of mononuclear phagocytes in prion neuroinvasion from the skin , 2012, Journal of leukocyte biology.

[57]  S. Prusiner,et al.  Salivary prions in sheep and deer , 2012, Prion.

[58]  Deyu Li,et al.  TDP-43 is intercellularly transmitted across axon terminals , 2015, The Journal of cell biology.

[59]  A. Chakrabartty,et al.  Monomeric Cu,Zn-superoxide Dismutase Is a Common Misfolding Intermediate in the Oxidation Models of Sporadic and Familial Amyotrophic Lateral Sclerosis*[boxs] , 2004, Journal of Biological Chemistry.

[60]  J. Trojanowski,et al.  Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice , 2015, Neurobiology of Disease.

[61]  Ji-Eun Suk,et al.  Transmission of Synucleinopathies in the Enteric Nervous System of A53T Alpha-Synuclein Transgenic Mice , 2011, Experimental neurobiology.

[62]  J. Chapuis,et al.  Quaternary Structure of Pathological Prion Protein as a Determining Factor of Strain-Specific Prion Replication Dynamics , 2013, PLoS pathogens.

[63]  Richard D. Leapman,et al.  Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.

[64]  M. Goedert,et al.  The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy , 2000 .

[65]  J. Castilla,et al.  Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like Mechanism , 2013, International journal of cell biology.

[66]  P. Andersen,et al.  Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease. , 2016, The Journal of clinical investigation.

[67]  N. Ishiguro,et al.  Transmission of Systemic AA Amyloidosis in Animals , 2014, Veterinary pathology.

[68]  D. Walsh,et al.  Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host , 2006, Science.

[69]  J. Brion,et al.  Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study. , 1985, Journal of submicroscopic cytology.

[70]  D. Mann,et al.  Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau , 2015, Acta Neuropathologica.

[71]  J. Castilla,et al.  Animal models for prion-like diseases. , 2015, Virus research.

[72]  M. Jucker,et al.  Exogenous seeding of cerebral beta-amyloid deposition in beta APP-transgenic rats , 2012 .

[73]  X. Roucou,et al.  Aggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerization , 2013, Molecular Neurodegeneration.

[74]  Brian Spencer,et al.  Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein , 2009, Proceedings of the National Academy of Sciences.

[75]  P. Verstreken,et al.  Synaptic Contacts Enhance Cell-to-Cell Tau Pathology Propagation. , 2015, Cell reports.

[76]  Ruedi Aebersold,et al.  A cellular gene encodes scrapie PrP 27-30 protein , 1985, Cell.

[77]  R. Riek,et al.  NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.

[78]  Adriano Aguzzi,et al.  Prions: protein aggregation and infectious diseases. , 2009, Physiological reviews.

[79]  Gregor Bieri,et al.  Axonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1 , 2016, Acta Neuropathologica.

[80]  L. Lannfelt,et al.  NEURON-TO-NEURON TRANSMISSION OF ALPHA-SYNUCLEIN , 2014, Alzheimer's & Dementia.

[81]  V. Lee,et al.  Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles* , 2011, The Journal of Biological Chemistry.

[82]  M. Goedert,et al.  The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. , 2000, Annals of the New York Academy of Sciences.

[83]  G. Legname,et al.  Prion Protein-Specific Antibodies-Development, Modes of Action and Therapeutics Application , 2014, Viruses.

[84]  M. Margittai,et al.  Amplification of Tau Fibrils from Minute Quantities of Seeds , 2014, Biochemistry.

[85]  Sofia Nyström,et al.  Transmissibility of systemic amyloidosis by a prion-like mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Charles Duyckaerts,et al.  Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies , 2015, Acta Neuropathologica.

[87]  T. Alper,et al.  The exceptionally small size of the scrapie agent. , 1966, Biochemical and biophysical research communications.

[88]  L. Grinberg,et al.  Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies , 2014, Neuron.

[89]  R. Ridley,et al.  Very long term studies of the seeding of beta-amyloidosis in primates. , 2006, Journal of neural transmission.

[90]  S. Prusiner,et al.  Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity , 1996, Science.

[91]  Armin Giese,et al.  Different species of alpha-synuclein oligomers induce calcium influx and seeding. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[92]  M. Cookson,et al.  α‐Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[93]  M. Goedert,et al.  Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice , 2013, Acta Neuropathologica.

[94]  Mark Head,et al.  Preclinical variant CJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004 .

[95]  Robert H. Brown,et al.  Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. , 2010, Human molecular genetics.

[96]  P. Tsvetkov,et al.  Peripherally Applied Synthetic Peptide isoAsp7-Aβ(1-42) Triggers Cerebral β-Amyloidosis , 2013, Neurotoxicity Research.

[97]  P E Fraser,et al.  A kinetic model for amyloid formation in the prion diseases: importance of seeding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[98]  J. Rumfeldt,et al.  Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[99]  R. Marsh,et al.  Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent , 1992, Journal of virology.

[100]  A. Einstein,et al.  Superoxide dismutase 1 and amyotrophic lateral sclerosis , 2005 .

[101]  E. Kandel,et al.  A Neuronal Isoform of the Aplysia CPEB Has Prion-Like Properties , 2003, Cell.

[102]  Jane Y. Wu,et al.  A Drosophila model for TDP-43 proteinopathy , 2010, Proceedings of the National Academy of Sciences.

[103]  W. S. Gordon Advances in veterinary research. , 1946, The Veterinary record.

[104]  C. Soto,et al.  Aggregate-Depleted Brain Fails to Induce Aβ Deposition in a Mouse Model of Alzheimer's Disease , 2014, PloS one.

[105]  T. Crow,et al.  Experimental induction of beta-amyloid plaques and cerebral angiopathy in primates. , 1993, Annals of the New York Academy of Sciences.

[106]  A. Aguzzi,et al.  Cell Biology of Prions and Prionoids: A Status Report. , 2016, Trends in cell biology.

[107]  T. Crow,et al.  Induction of β(A4)-amyloid in primates by injection of Alzheimer’s disease brain homogenate , 2007, Molecular Neurobiology.

[108]  J. Trojanowski,et al.  Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells , 2009, Proceedings of the National Academy of Sciences.

[109]  John Q Trojanowski,et al.  A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. , 2010, The American journal of pathology.

[110]  J. Kordower,et al.  Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat , 2011, Neurobiology of Disease.

[111]  M. Bruce TSE strain variation. , 2003, British medical bulletin.

[112]  Tapan P. Patel,et al.  Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.

[113]  J. Ironside,et al.  Variant CJD , 2014, Journal of the Neurological Sciences.

[114]  Armin Giese,et al.  Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding , 2007, The Journal of Neuroscience.

[115]  B. Chesebro,et al.  Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain , 1985, Nature.

[116]  P. Westermark,et al.  Serum amyloid A and protein AA: Molecular mechanisms of a transmissible amyloidosis , 2009, FEBS letters.

[117]  M. Diamond,et al.  Propagation of Tau Misfolding from the Outside to the Inside of a Cell* , 2009, Journal of Biological Chemistry.

[118]  B. Caughey,et al.  Uptake and Neuritic Transport of Scrapie Prion Protein Coincident with Infection of Neuronal Cells , 2022 .

[119]  A. Gitler,et al.  Molecular Determinants and Genetic Modifiers of Aggregation and Toxicity for the ALS Disease Protein FUS/TLS , 2011, PLoS biology.

[120]  Noo Li Jeon,et al.  β‐Amyloid is transmitted via neuronal connections along axonal membranes , 2014, Annals of neurology.

[121]  D. Taylor Inactivation of prions by physical and chemical means. , 1999, The Journal of hospital infection.

[122]  N. Maragakis,et al.  Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo , 2011, Proceedings of the National Academy of Sciences.

[123]  M. Groschup,et al.  Spread of classic BSE prions from the gut via the peripheral nervous system to the brain. , 2012, The American journal of pathology.

[124]  A. Aguzzi,et al.  Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting. , 2016, Swiss medical weekly.

[125]  S. Prusiner,et al.  Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice , 2014, Proceedings of the National Academy of Sciences.

[126]  J. Griffith,et al.  Nature of the Scrapie Agent: Self-replication and Scrapie , 1967, Nature.

[127]  M. Giugliano,et al.  α-Synuclein strains cause distinct synucleinopathies after local and systemic administration , 2015, Nature.

[128]  J. Trojanowski,et al.  Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like Tauopathy , 2013, The Journal of Neuroscience.

[129]  John Bartlett,et al.  Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004 .

[130]  J. Lah,et al.  Exogenous seeding of cerebral β‐amyloid deposition in βAPP‐transgenic rats , 2012, Journal of neurochemistry.

[131]  P. Roller,et al.  Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. , 1993, The Journal of biological chemistry.

[132]  G. Bloom,et al.  Alzheimer disease , 2013, Prion.

[133]  J. Jia,et al.  Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS , 2012, Molecular Neurodegeneration.

[134]  A. Aguzzi,et al.  Induction of cerebral β-amyloidosis: Intracerebral versus systemic Aβ inoculation , 2009, Proceedings of the National Academy of Sciences.

[135]  K. Ando,et al.  Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model. , 2010, Biochemical Society transactions.

[136]  C. Anfinsen Principles that govern the folding of protein chains. , 1973, Science.

[137]  D. Mann,et al.  Prion-like properties of pathological TDP-43 aggregates from diseased brains. , 2013, Cell reports.

[138]  E A Hoover,et al.  Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). , 1999, The Journal of general virology.

[139]  Rebecca B. Smith,et al.  RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. , 2013, Human molecular genetics.

[140]  A. Zlotnick,et al.  One protein, at least three structures, and many functions. , 2013, Structure.

[141]  M. Hasegawa,et al.  Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils* , 2016, The Journal of Biological Chemistry.

[142]  Brian C Coe,et al.  Alzheimer's Disease-Like Pathology Induced by Amyloid-β Oligomers in Nonhuman Primates , 2014, The Journal of Neuroscience.

[143]  M. Diamond,et al.  Interaction with Polyglutamine Aggregates Reveals a Q/N-rich Domain in TDP-43* , 2010, The Journal of Biological Chemistry.

[144]  Kurt Giles,et al.  Bioluminescence imaging of Aβ deposition in bigenic mouse models of Alzheimer's disease , 2011, Proceedings of the National Academy of Sciences.

[145]  K. Ando,et al.  Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model. , 2011, The American journal of pathology.

[146]  H. Fraser,et al.  Scrapie strain variation and its implications. , 1991, Current topics in microbiology and immunology.

[147]  A. Gitler,et al.  TDP-43 Is Intrinsically Aggregation-prone, and Amyotrophic Lateral Sclerosis-linked Mutations Accelerate Aggregation and Increase Toxicity* , 2009, The Journal of Biological Chemistry.

[148]  J. Collinge,et al.  Superoxide Dismutase 1 and tgSOD1G93A Mouse Spinal Cord Seed Fibrils, Suggesting a Propagative Cell Death Mechanism in Amyotrophic Lateral Sclerosis , 2010, PloS one.

[149]  R. Hauser,et al.  Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.

[150]  Dennis W. Dickson,et al.  Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies , 2015, Acta Neuropathologica.

[151]  A. Björklund,et al.  Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo , 2012, PloS one.

[152]  A. Goldberg,et al.  Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry , 2011, The EMBO journal.

[153]  A. Aguzzi,et al.  Mice devoid of PrP are resistant to scrapie , 1993, Cell.

[154]  E. Marcello,et al.  Modeling Alzheimer’s disease: from past to future , 2013, Front. Pharmacol..

[155]  S. Gustincich,et al.  Defined α-synuclein prion-like molecular assemblies spreading in cell culture , 2014, BMC Neuroscience.

[156]  Michael Wolff,et al.  Seeding induced by α‐synuclein oligomers provides evidence for spreading of α‐synuclein pathology , 2009, Journal of neurochemistry.

[157]  M. Halliday,et al.  Prions: Generation and Spread Versus Neurotoxicity , 2014, The Journal of Biological Chemistry.

[158]  David S Wishart,et al.  Intermolecular transmission of superoxide dismutase 1 misfolding in living cells , 2011, Proceedings of the National Academy of Sciences.

[159]  Martin Beibel,et al.  Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.

[160]  J. Griffith,et al.  Self-replication and scrapie. , 1967, Nature.

[161]  Mostafa Langarizadeh,et al.  A novel method for fuzzy diagnostic system design , 2018, Medical journal of the Islamic Republic of Iran.

[162]  D. Cleveland,et al.  The Seeds of Neurodegeneration: Prion-like Spreading in ALS , 2011, Cell.

[163]  Clemens F. Kaminski,et al.  Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology* , 2013, The Journal of Biological Chemistry.

[164]  Nicolas Chenouard,et al.  Prions hijack tunnelling nanotubes for intercellular spread , 2009, Nature Cell Biology.

[165]  U. Sengupta,et al.  Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau , 2012, Scientific Reports.

[166]  A. Heiseke,et al.  Autophagy, prion infection and their mutual interactions. , 2010, Current issues in molecular biology.

[167]  E. Waxman,et al.  A novel, high‐efficiency cellular model of fibrillar α‐synuclein inclusions and the examination of mutations that inhibit amyloid formation , 2010, Journal of neurochemistry.

[168]  Miss A.O. Penney (b) , 1974, The New Yale Book of Quotations.

[169]  T. Baron Mouse models of prion disease transmission. , 2002, Trends in molecular medicine.

[170]  R. Barker,et al.  Anti-amyloid Compounds Inhibit α-Synuclein Aggregation Induced by Protein Misfolding Cyclic Amplification (PMCA)* , 2014, The Journal of Biological Chemistry.

[171]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[172]  J. Collinge,et al.  Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS , 2015, PLoS pathogens.

[173]  Jun-tao Guo,et al.  Inflammation-Dependent Cerebral Deposition of Serum Amyloid A Protein in a Mouse Model of Amyloidosis , 2002, The Journal of Neuroscience.

[174]  Michael W. Miller,et al.  Prion disease: Horizontal prion transmission in mule deer , 2003, Nature.

[175]  J. Mitchison Cell Biology , 1964, Nature.

[176]  F. Kametani,et al.  Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease , 2008, Proceedings of the National Academy of Sciences.

[177]  Hans-Ulrich Demuth,et al.  Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology , 2008, Nature Medicine.

[178]  B. Meier,et al.  Structural and functional characterization of two alpha-synuclein strains , 2013, Nature Communications.

[179]  C. Olanow,et al.  Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion‐Like Disorder? , 2013, Movement disorders : official journal of the Movement Disorder Society.

[180]  D. D. Di Monte,et al.  Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury , 2015, Acta neuropathologica communications.

[181]  Arturo Casadevall,et al.  Host-Pathogen Interactions: Basic Concepts of Microbial Commensalism, Colonization, Infection, and Disease , 2000, Infection and Immunity.

[182]  P. Liberski,et al.  Kuru: Its ramifications after fifty years , 2009, Experimental Gerontology.

[183]  R. Will,et al.  Laboratory diagnosis of variant Creutzfeldt–Jakob disease , 2000, Histopathology.

[184]  J. Winderickx,et al.  Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies , 2014, Acta neuropathologica communications.

[185]  M. Staufenbiel,et al.  Induction of Tau Pathology by Intracerebral Infusion of Amyloid-β-Containing Brain Extract and by Amyloid-β Deposition in APP × Tau Transgenic Mice , 2007 .

[186]  M. Murray,et al.  Transmission of Soluble and Insoluble &agr;-Synuclein to Mice , 2015, Journal of neuropathology and experimental neurology.

[187]  Elisabet Englund,et al.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.

[188]  Bin Zhang,et al.  Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons , 2013, Cell.

[189]  John Q. Trojanowski,et al.  Amyotrophic lateral sclerosis—a model of corticofugal axonal spread , 2013, Nature Reviews Neurology.

[190]  E. Chang,et al.  Diffusible amyloid oligomers trigger systemic amyloidosis in mice. , 2008, The Biochemical journal.

[191]  E. Masliah,et al.  Protein profiling of isolated uterine AA amyloidosis causing fetal death in goats , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[192]  S. Prusiner Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[193]  Christian Münch,et al.  Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells , 2011, Proceedings of the National Academy of Sciences.

[194]  Lawrence Rajendran,et al.  The Transcellular Spread of Cytosolic Amyloids, Prions, and Prionoids , 2009, Neuron.

[195]  D. Dickson,et al.  Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis , 2012, Molecular Neurodegeneration.

[196]  P. Brown Iatrogenic Creutzfeldt-Jakob disease. , 1990, Australian and New Zealand journal of medicine.

[197]  R. Baloh TDP‐43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration , 2011, The FEBS journal.

[198]  J. Linehan,et al.  Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic , 2013 .

[199]  T. Golde,et al.  Conformational templating of α-synuclein aggregates in neuronal-glial cultures , 2013, Molecular Neurodegeneration.

[200]  L. Schonberger,et al.  Iatrogenic Creutzfeldt-Jakob Disease, Final Assessment , 2012, Emerging infectious diseases.

[201]  J. Castilla,et al.  In Vitro Generation of Infectious Scrapie Prions , 2005, Cell.

[202]  M. Simmons,et al.  Disease characteristics of bovine spongiform encephalopathy following inoculation into mice via three different routes , 2013, International journal of experimental pathology.

[203]  M. Spillantini,et al.  Frontotemporal Dementia with Tau Pathology , 2007, Neurodegenerative Diseases.

[204]  J. Chapuis,et al.  Efficient dissemination of prions through preferential transmission to nearby cells. , 2007, The Journal of general virology.

[205]  A. Karch,et al.  On the issue of transmissibility of Alzheimer disease , 2012, Prion.

[206]  R. Cappai,et al.  Packaging of prions into exosomes is associated with a novel pathway of PrP processing , 2007, The Journal of pathology.

[207]  M. Neunlist,et al.  Activity‐dependent secretion of alpha‐synuclein by enteric neurons , 2013, Journal of neurochemistry.

[208]  G. Baron,et al.  GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells , 2010, The EMBO journal.

[209]  N. Kanu,et al.  Transfer of Scrapie Prion Infectivity by Cell Contact in Culture , 2002, Current Biology.

[210]  E. M. Jones,et al.  Fibril Conformation as the Basis of Species- and Strain-Dependent Seeding Specificity of Mammalian Prion Amyloids , 2005, Cell.

[211]  W. Faigle,et al.  Cells release prions in association with exosomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[212]  T. Crow,et al.  Evidence for the experimental transmission of cerebral beta-amyloidosis to primates. , 1993, International journal of experimental pathology.

[213]  A. Buschmann,et al.  Rodent models for prion diseases. , 2008, Veterinary research.

[214]  A. Salazar,et al.  Alzheimer's Disease and Transmissible Virus Dementia (Creutzfeldt‐Jakob Disease) , 1982, Annals of the New York Academy of Sciences.

[215]  A. Hill,et al.  Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms , 2014, Proceedings of the National Academy of Sciences.

[216]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[217]  Jacob I. Ayers,et al.  Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways , 2015, Acta Neuropathologica.

[218]  Y. Ling Experimental production of amyloidosis in ducks. , 1992, Avian pathology : journal of the W.V.P.A.

[219]  J. Trojanowski,et al.  Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice , 2012, The Journal of experimental medicine.

[220]  S. Prusiner,et al.  Identification of a protein that purifies with the scrapie prion. , 1982, Science.

[221]  Ronald Melki,et al.  Neuron‐to‐neuron transmission of α‐synuclein fibrils through axonal transport , 2012, Annals of neurology.

[222]  K. Nilsson,et al.  Seeded strain‐like transmission of β‐amyloid morphotypes in APP transgenic mice , 2013, EMBO reports.

[223]  Fei Wang,et al.  Generating a Prion with Bacterially Expressed Recombinant Prion Protein , 2010, Science.

[224]  L. Greensmith,et al.  A Nonsense Mutation in Mouse Tardbp Affects TDP43 Alternative Splicing Activity and Causes Limb-Clasping and Body Tone Defects , 2014, PloS one.

[225]  J. Julien,et al.  Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis , 2007, Proceedings of the National Academy of Sciences.

[226]  Chen Wang,et al.  An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity , 2011, Nature Structural &Molecular Biology.

[227]  P. Westermark,et al.  Amyloidogenic potential of foie gras , 2007, Proceedings of the National Academy of Sciences.

[228]  Ji Han Kim,et al.  A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. , 2011, Human molecular genetics.

[229]  D. Vaux,et al.  Heterologous Amyloid Seeding: Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease , 2007, PloS one.

[230]  J. Šponarová,et al.  AA-Amyloidosis Can Be Transferred by Peripheral Blood Monocytes , 2008, PloS one.

[231]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[232]  Martin Hallbeck,et al.  Spreading of amyloid-β peptides via neuritic cell-to-cell transfer is dependent on insufficient cellular clearance , 2014, Neurobiology of Disease.

[233]  P. Harrison,et al.  Classifying prion and prion-like phenomena , 2014, Prion.

[234]  J. Castilla,et al.  De novo induction of amyloid-β deposition in vivo , 2012, Molecular Psychiatry.

[235]  P. Baatsen,et al.  Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo , 2016, Acta Neuropathologica.

[236]  T. Hortobágyi,et al.  Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion , 2012, Acta Neuropathologica.

[237]  M. Samsonova,et al.  Conservative system for dosage-dependent modulation of translational fidelity in eukaryotes. , 1992, Biochimie.

[238]  Zeshan Ahmed,et al.  A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity , 2014, Acta Neuropathologica.

[239]  R. Marsh,et al.  Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy , 1994, Journal of virology.

[240]  N. Nukina,et al.  A Seeding Reaction Recapitulates Intracellular Formation of Sarkosyl-insoluble Transactivation Response Element (TAR) DNA-binding Protein-43 Inclusions*♦ , 2011, The Journal of Biological Chemistry.

[241]  I. Pattison RESISTANCE OF THE SCRAPIE AGENT TO FORMALIN. , 1965, Journal of comparative pathology.

[242]  F. Kametani,et al.  Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation. , 2016, Human molecular genetics.